THREE-DRUG REGIMEN WITH EPIRUBICIN, PACLITAXEL AND ETOPOSIDE (EPE) IN THE TREATMENT OF EXTENSIVE SCLC: A PHASE I–II STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles